首页 › 基金 › Paradigm Biocapital Advisors LP › ERAS

Paradigm Biocapital Advisors LP 对 ERAS 的持仓历史

ERASCA INC · 医疗保健

Paradigm Biocapital Advisors LP 在 Q3 2026 的 13F 申报中披露持有 ERAS(ERASCA INC)7,998,257 股,市值约 US$117.3M,约占其申报组合的 2.33%,在其申报持仓中市值排名第 14 位。 Paradigm Biocapital Advisors LP 最近 10 个申报季度中有 10 个季度披露了 ERAS 持仓,最早可追溯至 Q2 2024。

最新持仓 (Q3 2026)8.00M 股
申报持仓市值$117.25M
组合权重2.33%
首次申报Q2 2024
最近变动减持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Paradigm Biocapital Advisors LP 对 ERAS 的持仓演变

Paradigm Biocapital Advisors LP 于 Q2 2024 首次披露 ERAS 持仓:7,250,000 股(约 US$17.1M)。 该持仓在 Q2 2026 达到峰值 9,550,000 股,市值约 US$175.0M。 在 10 次申报中,Paradigm Biocapital Advisors LP 5 次增持、3 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 7,998,257 股、市值约 US$117.3M,环比减持 -1,551,743 股。。 持仓曾出现大幅变动:Q3 2024 增持约 47% (随后一个季度股价下跌 8%)、Q1 2026 减持约 27% (随后一个季度股价上涨 13%)。

逐季持仓明细

季度股数金额变化
Q2 2024 7.25M $17.11M 新进
Q3 2024 10.67M $29.12M 增持
Q4 2024 10.75M $26.99M 增持
Q1 2025 10.80M $14.80M 持有
Q2 2025 11.91M $15.12M 增持
Q3 2025 13.56M $29.56M 增持
Q4 2025 14.16M $52.67M 增持
Q1 2026 10.39M $168.15M 减持
Q2 2026 9.55M $174.96M 减持
Q3 2026 8.00M $117.25M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ERAS 与 13F 数据

ERAS(ERASCA INC)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 ERAS,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$329.1M), Venrock Adviser, LLC (US$327.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ERAS 的基金

查看 ERAS 的全部基金持有人 →

常见问题

How long has Paradigm Biocapital Advisors LP held ERAS?

Paradigm Biocapital Advisors LP has disclosed ERAS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Paradigm Biocapital Advisors LP's current position in ERAS?

As of Q3 2026, Paradigm Biocapital Advisors LP holds 8.00M shares of ERAS (ERASCA INC), valued at $117.25M, representing 2.33% of its reported portfolio and ranking #14.

Has Paradigm Biocapital Advisors LP been buying or selling ERAS?

In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP reduced its position in ERAS. The position peaked in Q2 2026 at 9.55M shares.

Which other funds hold ERAS?

Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.